Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Malignant Melanoma

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Malignant Melanoma in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonchak, JG1
Eby, JM1
Willenborg, KA1
Chrobak, D1
Henning, SW1
Krzywiec, A1
Johnson, SL1
Le Poole, IC1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Malignant Melanoma

ArticleYear
Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin.
    Archives of biochemistry and biophysics, 2014, Dec-01, Volume: 563

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Administration, Topical; Animals; Cell Differentiation; Cell

2014